APA Annual Meeting
How to Submit a Workshop
Format Description:




90-minute session
Intended to encourage interaction and collective learning.
Should include lively and energetic discussion and Q &A from the presenters and audience. There
should be a dedicated 30 minutes to interaction with the audience.
Please describe in the abstract the technique used by presenters to create an interactive environment
(i.e. small groups).
Checklist for your submission:








Chair MUST be submitter
Overall Title of the workshop (maximum of 150 characters, with spaces)
Participants information
o Completed Profile by all participants **
Educational Learning Objectives
o Minimum of three objectives, maximum of five
o Maximum 200 characters with spaces per objective
o Example of learning objective: Please use active words like demonstrate, understand, provide
in the statement. At the conclusion of this presentation the participant should be able to: 1)
Demonstrate…..2) Provide…………….3) Understand……………………
Overall workshop abstract (maximum of 3000 characters, with spaces)
o The abstract should be a concise description of results, findings, or the importance of
presentation. It should provide a strong summary of the presentation(s).
Select Topic (Track is optional)
Presenters must be available to present at the Annual Meeting.
Create agenda for the 90-minute workshop with enough time for substantial interactive and Q &A.
The tabs at the top will stay red if you have not completed all items; it will become green after you have
completed all steps. After all tabs are green ensure you have FINALIZED your submission. Any submission
that is not finalized will NOT be sent to grading.
**All presenters must have completed profiles and financial disclosures for the submission to be considered for review by the
Scientific Program Committee. All presenters must register for the meeting prior to the presentation**
Example of Workshop Submissions
MILD TRAUMATIC BRAIN INJURY: ASSESSMENT AND INITIAL MANAGEMENT WITH
NEUROPHARMACOLOGY
Chairs: David B. FitzGerald, M.B.A., M.D., Josepha A. Cheong, M.D.
Speakers: David B. FitzGerald, M.B.A., M.D., Josepha A. Cheong, M.D.
EDUCATIONAL OBJECTIVE:
At the conclusion of the session, the participant should be able to: 1) Understand multiple areas of
impairment/symptoms brought about by mild TBI ; 2) Identify pharmacological interventions which are
appropriate for treating mild TBI; 3) Identify non-pharmacological interventions for treating mild TBI.
SUMMARY:
Loss of consciousness or alteration of consciousness for a short duration (less than 30 minutes) is thought to
be a relatively benign experience, either in military settings or in civilian settings. The strengths and
weaknesses of the current classification system of TBI are reviewed, with examples. A proportion of those
experiencing brief loss of consciousness or alteration of consciousness (or mild TBI) have chronic adverse
symptoms, which are only now being characterized. The magnitude of the problem in both military and
civilian areas is discussed. Recent imaging data using conventional anatomical imaging as well as a review of
diffusion weighted imaging after mild TBI are also presented to provide better insight as to mechanisms of
damage. Current therapeutic approaches, both pharmacologic and non-pharmacologic approaches are
discussed.
A RESIDENT'S GUIDE TO BORDERLINE PERSONALITY DISORDER: FROM THE EXPERTS
Chair: Brian Palmer, M.D., M.P.H.
Speakers: John G. Gunderson, M.D., Kenneth R. Silk, M.D., Perry Hoffman, Ph.D.
EDUCATIONAL OBJECTIVE:
At the conclusion of the session, the participant should be able to: 1) Diagnose BPD and understand its
relationship to other disorders; 2) Structure an effective psychotherapy for BPD; 3) Thoughtfully choose
psychopharmacologic approaches that fit within a formulation of a patient's problems; 4) Effectively
integrate family work into a treatment plan; 5) Establish a concrete plan for integrating BPD into their further
psychiatric training.
SUMMARY:
Patients with BPD represent approximately 20% of both inpatient and outpatient clinical practice, and their
effective treatment requires specific knowledge, skills, and attitudes that will be addressed in this workshop.
This workshop is designed for and limited to residents, fellows, and medical students who, in training, often
struggle with the treatment of these patients. In a highly interactive format, trainees will learn from and
along with experts in the field of borderline personality disorder (BPD) to broaden and deepen their
understanding of the disorder and its treatment. Alternating brief presentations of salient points with
audience participation will allow participants to increase their knowledge and skill and to synthesize and
apply the content as presented in the workshop. The workshop will be presented in two sessions (Part I and
Part II). The workshop moves from an overview of BPD to essentials of psychotherapy and
psychopharmacology, family therapy, and residency training objectives. Specifically, participants will review
the diagnosis of BPD and its relationship with other disorders in order to build a basis for case formulation.
Following this, the workshop examines core features of effective psychotherapy as well as (features) aspects
of treatments likely to make patients worse. Strategies and common pitfalls in psychopharmacologic
treatment for BPD are examined, with case material from both experts and participants. Principles of family
involvement (follow) are presented, including data supporting the idea that families can and should learn
effective ways of decreasing reactivity and increasing effective validation.
Finally, objectives for residency education will help participants bring content from the workshop and
integrate it with their current training. Participants are encouraged to attend both parts, though we will, in
Part II, review material from Part I, so if necessary either session could be attended independently.
Example of Workshop Submission
WHAT TO DO WHILE WAITING FOR BETTER ANTIDEPRESSANT TREATMENTS: ANTIDEPRESSANT
EFFICACY AND OPTIONS
Chair: Jerrold F. Rosenbaum, M.D.
EDUCATIONAL OBJECTIVE:
At the conclusion of the session, the participant should be able to: 1) Address recent challenges in media to
usefulness of antidepressants; 2) Review methodological challenges to evaluating antidepressant efficacy; 3)
Consider options for treating depression; 4) Participate in a case-based discussion that illustrates the
challenges and options while being on this course .
SUMMARY:
There is a broad range of views of the role of medications in the treatment of Depressive Disorders ranging
from strongly positive advocacy of their efficacy and usefulness to claims of being no better than side-effect
laden placebos. The views that support the latter opinion fail to consider the real methodological challenges
to proving efficacy in large clinical trials as currently conducted. Further, practitioners know that standard
dose monotherapy is unlikely to achieve and sustain benefits for the majority of sufferers over time. Using a
case based history, this interactive workshop will review options and discuss these issues.